食管癌药物治疗临床研究进展  

Progress of clinical medication for esophageal cancer

作　　者：蒋苏豫[1] 李苏宜[1] 

机构地区：[1]东南大学附属中大医院临床肿瘤中心,江苏南京210009

出　　处：《中国癌症杂志》2009年第3期228-233,共6页China Oncology

摘　　要：食管癌药物治疗可以显著提高有效性、延长患者生存期,化疗、放疗与手术联合是目前治疗食管癌的主要综合治疗模式。本文就食管癌药物治疗临床研究文献进行复习和思考。依据近年来临床研究新证据,分别就新型化疗药物治疗食管癌在综合治疗中扮演不同角色时的有效性和安全性进行系统综述。文章还初步探讨了应用新靶点药物治疗食管癌的价值。The combination of chemotherapy, radiotherapy and surgery is the current main strategy for esophageal cancer, and chemotherapy plays a vital role in terms of prolongation of survival and quality of life. The development of new chemotherapeutic agents for the treatment of esophageal cancer has been given much attention in the past. This review summarized the efficacy and safety of new agents based on clinical evidence and the roles of those agents in the multidisciplinary treatment of esophageal cancer. It also included the progress of molecular targeting therapy for the disease.

关 键 词：食管癌 药物治疗 综合治疗 

分 类 号：R735.1[医药卫生—肿瘤] R730.53[医药卫生—临床医学]